024 Pharma Profile



Odds of Distress

Check how we calculate scores
Equity ratings for 024 Pharma are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting July 23, 2019 and ending today October 21, 2019. Click here to learn more.

024 Pharma Profile

Its products include vitamin and mineral supplements stress release, joint, heart health, and weight-loss products and skin care, hair, and anti-aging products. The company was formerly known as B Green Innovations, Inc. and changed its name to 024 Pharma, Inc. in October 2016. 024 Pharma, Inc. was incorporated in 2004 and is based in West Palm Beach, Florida. 024 Pharma is traded on BATS Exchange in USA. more
Name024 Pharma
President CEO, DirectorMiro ZecevicView All
Macroaxis Advice
InstrumentUSA OTC Stock View All
Business Address224 Datura Street
ExchangeBATS Exchange
SectorConsumer Defensive
IndustryPackaged Foods
Phone732 696 9333
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2018
Most Recent QuarterMarch 31, 2017
Last Fiscal Year EndDecember 31, 2016
024 Pharma [EEIG] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with current market capitalization of 328.59 K. 024 Pharma conducts business under Consumer Defensive sector and is part of Packaged Foods industry. The entity has 13.45 K outstanding shares.
Check 024 Pharma Probability Of Bankruptcy

024 Pharma Target Price Odds Analysis

Odds Below 2.5HorizonTargetOdds Above 2.5
66.36%30 days 2.50 33.54%
Based on normal probability distribution, the odds of 024 Pharma to move above current price in 30 days from now is about 33.54 (This 024 Pharma probability density function shows the probability of 024 Pharma OTC Stock to fall within a particular range of prices over 30 days) .

024 Pharma Risk Profiles

024 Pharma Key Fundamentals

024 Pharma Against Markets

Did you try this?

Run Instant Ratings Now


Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module
Additionally see Investing Opportunities. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.
Search macroaxis.com